| |
| |
|
| Insider
Information: |
Czirr James C |
| Relationship: |
10% Owner |
| City: |
Sandpoint |
| State: |
ID |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,168,940 |
|
|
Indirect Shares
|
5,922,207 |
|
|
| Direct
Value |
$16,039,244 |
|
|
|
Indirect Value
|
$15,397,738 |
|
|
| Total
Shares |
12,091,147 |
|
|
| Total
Value |
$31,436,982 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -84.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,100 |
4,854,768 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
S |
$5.75 |
$100,050 |
D/D |
(17,400) |
4,837,368 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,100 |
31,100 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2003-12-12 |
4 |
S |
$3.79 |
$284,250 |
D/D |
(75,000) |
4,779,768 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-02-28 |
4 |
AS |
$3.36 |
$67,200 |
D/D |
(20,000) |
0 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-03-01 |
4 |
AS |
$3.24 |
$64,800 |
D/D |
(20,000) |
4,312,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-04-03 |
4 |
AS |
$3.93 |
$78,600 |
D/D |
(20,000) |
4,292,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-05-02 |
4 |
AS |
$3.30 |
$36,300 |
D/D |
(11,000) |
0 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-05-03 |
4 |
AS |
$3.25 |
$29,250 |
D/D |
(9,000) |
0 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-06-01 |
4 |
AS |
$3.22 |
$64,400 |
D/D |
(20,000) |
0 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-06-12 |
4 |
AS |
$3.25 |
$65,000 |
D/D |
(20,000) |
4,232,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-07-07 |
4 |
AS |
$2.65 |
$26,500 |
D/D |
(10,000) |
4,222,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-07-10 |
4 |
AS |
$3.00 |
$15,000 |
D/D |
(5,000) |
4,217,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-01-21 |
4 |
S |
$0.08 |
$20,000 |
D/D |
(250,000) |
3,597,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
4,097,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-03-31 |
4 |
A |
$0.22 |
$1,320 |
I/I |
6,000 |
139,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-09-30 |
4 |
A |
$0.33 |
$72,315 |
I/I |
219,136 |
420,804 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-12-31 |
4 |
A |
$0.28 |
$72,808 |
I/I |
260,027 |
680,831 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-03-31 |
4 |
A |
$0.44 |
$2,640 |
I/I |
6,000 |
151,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-03-31 |
4 |
A |
$1.08 |
$5,975 |
I/I |
5,532 |
173,232 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-03-31 |
4 |
A |
$1.04 |
$395,694 |
I/I |
380,475 |
2,482,223 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-06-30 |
4 |
A |
$1.22 |
$464,180 |
I/I |
380,475 |
2,862,698 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-06-30 |
4 |
OE |
$1.22 |
$4,379,800 |
I/I |
3,590,000 |
6,452,698 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-07-12 |
4 |
GD |
$1.08 |
$34,560 |
D/D |
32,000 |
4,065,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-09-30 |
4 |
OE |
$0.50 |
$1,205,000 |
I/I |
2,410,000 |
8,862,698 |
0 |
- |
|
107 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
